BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 32244013)

  • 21. Hematoporphyrin Monomethyl Ether Photodynamic Therapy of Port Wine Stain: Narrative Review.
    Diao P; Han C; Li X; Yang Y; Jiang X
    Clin Cosmet Investig Dermatol; 2023; 16():1135-1144. PubMed ID: 37139084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic Therapy for Treatment of Disease in Children-A Review of the Literature.
    Mazur A; Koziorowska K; Dynarowicz K; Aebisher D; Bartusik-Aebisher D
    Children (Basel); 2022 May; 9(5):. PubMed ID: 35626872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of hemoporfin in photodynamic therapy for port-wine stain: a multicenter and open-labeled phase IIa study.
    Zhao Y; Zhou Z; Zhou G; Tu P; Zheng Q; Tao J; Gu Y; Zhu X
    Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):17-23. PubMed ID: 21198878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of hemoporfin photodynamic therapy for pulsed dye laser-resistant facial port-wine stains in 107 children: A retrospective study.
    Zhang LC; Yang J; Huang YB; Bi MY
    Indian J Dermatol Venereol Leprol; 2022; 88(2):275. PubMed ID: 34672476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of facial port-wine stains resistant to pulsed dye laser.
    Zhang M; Wu Q; Lin T; Guo L; Ge Y; Zeng R; Yang Y; Rong H; Jia G; Huang Y; Fang J; Shi H; Zhao W; Chen S; Cai P
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101820. PubMed ID: 32428574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains.
    Han Y; Ying H; Zhang X; Yu W; Cen Q; Chen X; Qiu Y; Chen H; Jin Y; Ma G; Lin X
    J Dermatol; 2020 Apr; 47(4):348-355. PubMed ID: 32012364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between treatment reactions and treatment efficiency of Hemoporfin-photodynamic therapy on port wine stains: A prospective double blind randomized controlled trial.
    Tang Y; Xie H; Li J; Jian D
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():171-178. PubMed ID: 28216012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermoscopy predicts outcome in hemoporfin-mediated photodynamic therapy of port-wine stains: A prospective observational study.
    Li Y; Wang X; Liu Y; Tao J
    J Am Acad Dermatol; 2020 Dec; 83(6):1765-1767. PubMed ID: 32244013
    [No Abstract]   [Full Text] [Related]  

  • 29. Research progress of Hemoporfin--part one: preclinical study.
    Pu Y; Chen W; Yu Z
    Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):180-5. PubMed ID: 22594989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current clinical evidence is insufficient to support HMME-PDT as the first choice of treatment for young children with port wine birthmarks.
    Gao C; Nguyen V; Hochman ML; Gao L; Chen EH; Friedman HI; Nelson JS; Tan W
    Lasers Surg Med; 2024 Apr; 56(4):321-333. PubMed ID: 38506454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical study on clinical operation and post-treatment reactions of HMME-PDT in treatment of PWS.
    Zhang Y; Zou X; Chen H; Yang Y; Lin H; Guo X
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():253-256. PubMed ID: 29079350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Photodynamic therapy of neoplasms].
    Robak T
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):558-61. PubMed ID: 1480530
    [No Abstract]   [Full Text] [Related]  

  • 33. [Photodynamic therapy for early cervical cancer].
    Muroya T; Akiya T; Nakano M; Sakamoto M; Tenjin Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():158-68. PubMed ID: 15535226
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.